Viemed Healthcare (NASDAQ:VMD) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS

Viemed Healthcare (NASDAQ:VMD) issued its quarterly earnings data on Monday. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05), FiscalAI reports. The business had revenue of $78.10 million during the quarter, compared to the consensus estimate of $78.00 million. Viemed Healthcare had a return on equity of 10.52% and a net margin of 5.20%.

Viemed Healthcare Stock Performance

Shares of NASDAQ:VMD traded up $0.02 during trading on Monday, reaching $11.69. The stock had a trading volume of 400,989 shares, compared to its average volume of 267,900. Viemed Healthcare has a 52 week low of $5.96 and a 52 week high of $12.61. The firm has a market capitalization of $448.16 million, a price-to-earnings ratio of 31.59 and a beta of 1.10. The company has a quick ratio of 1.10, a current ratio of 1.22 and a debt-to-equity ratio of 0.06. The stock has a fifty day simple moving average of $11.12 and a two-hundred day simple moving average of $9.66.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Viemed Healthcare in a research report on Friday, July 17th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, Viemed Healthcare currently has an average rating of “Hold”.

Insiders Place Their Bets

In related news, insider William Frazier sold 10,000 shares of Viemed Healthcare stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total value of $117,200.00. Following the transaction, the insider owned 73,214 shares in the company, valued at $858,068.08. This trade represents a 12.02% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Timothy Smokoff sold 20,000 shares of the business’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $11.50, for a total transaction of $230,000.00. Following the transaction, the director directly owned 75,518 shares of the company’s stock, valued at approximately $868,457. This represents a 20.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 20.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Viemed Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Kemnay Advisory Services Inc. acquired a new position in shares of Viemed Healthcare during the 4th quarter worth about $46,000. Quarry LP acquired a new stake in Viemed Healthcare in the 3rd quarter valued at approximately $48,000. AQR Capital Management LLC bought a new position in Viemed Healthcare in the 1st quarter worth approximately $90,000. Invesco Ltd. increased its position in Viemed Healthcare by 25.5% in the 2nd quarter. Invesco Ltd. now owns 18,652 shares of the company’s stock worth $129,000 after buying an additional 3,795 shares during the period. Finally, MetLife Investment Management LLC lifted its holdings in shares of Viemed Healthcare by 52.7% during the fourth quarter. MetLife Investment Management LLC now owns 18,565 shares of the company’s stock worth $138,000 after buying an additional 6,408 shares during the last quarter. 74.24% of the stock is owned by institutional investors and hedge funds.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.